MoneyWorks4Me

Biocon - Quaterly Results

07 Aug 2025 Evaluate
The revenue zoomed 5.19% to Rs. 5371.00 millions for the quarter ended June 2025 as compared to Rs. 5106.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2025 is Rs. -83.00 millions as compared to Net Profit of Rs. 9.00 millions of corresponding quarter ended June 2024Operating Profit reported a sharp decline to 819.00 millions from 868.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 5371.00 5106.00 5.19 5371.00 5106.00 5.19 22426.00 21273.00 5.42
Other Income 613.00 419.00 46.30 613.00 419.00 46.30 2423.00 1930.00 25.54
PBIDT 819.00 868.00 -5.65 819.00 868.00 -5.65 4181.00 4557.00 -8.25
Interest 562.00 552.00 1.81 562.00 552.00 1.81 2369.00 1988.00 19.16
PBDT 257.00 316.00 -18.67 257.00 316.00 -18.67 7887.00 2714.00 190.60
Depreciation 333.00 305.00 9.18 333.00 305.00 9.18 1278.00 1211.00 5.53
PBT -76.00 11.00 -790.91 -76.00 11.00 -790.91 6609.00 1503.00 339.72
TAX 7.00 2.00 250.00 7.00 2.00 250.00 516.00 310.00 66.45
Deferred Tax -4.00 -22.00 -81.82 -4.00 -22.00 -81.82 11.00 159.00 -93.08
PAT -83.00 9.00 -1022.22 -83.00 9.00 -1022.22 6093.00 1193.00 410.73
Equity 6685.00 6003.00 11.36 6685.00 6003.00 11.36 6003.00 6003.00 0.00
PBIDTM(%) 15.25 17.00 -10.30 15.25 17.00 -10.30 18.64 21.42 -12.97
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..